GlaxoSmithkline Consumer Healthcare has reported results for the third quarter ended September 30, 2013.
The company has reported 14.30% rise in its net profit at Rs 146.93 crore for the quarter as compared to Rs 128.55 crore for the same quarter in the previous year. Total income of the company has increased by 19.45% at Rs 1057.47 crore for quarter under review as compared to Rs 885.31 crore for the quarter ended September 30, 2012.
GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.
